Related references
Note: Only part of the references are listed.Grade-dependent Proteomics Characterization of Kidney Cancer
Bertrand Perroud et al.
MOLECULAR & CELLULAR PROTEOMICS (2009)
Combined analysis of transcriptome and proteome data as a tool for the identification of candidate biomarkers in renal cell carcinoma
Barbara Seliger et al.
PROTEOMICS (2009)
Altered Detoxification Status and Increased Resistance to Oxidative Stress by K-Ras Transformation
Christian V. Recktenwald et al.
CANCER RESEARCH (2008)
Reverse transcriptase inhibitors induce cell differentiation and enhance the immunogenic phenotype in human renal clear-cell carcinoma
Matteo Landriscina et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Quantitative proteomic analysis to discover potential diagnostic markers and therapeutic targets in human renal cell carcinoma
Noboru Okamura et al.
PROTEOMICS (2008)
Candidate biomarkers in renal cell carcinoma
Barbara Seliger et al.
PROTEOMICS (2007)
Key clinical issues in renal cancer: a challenge for proteomics
Rosamonde E. Banks et al.
WORLD JOURNAL OF UROLOGY (2007)
Vascular endothelial growth factor-targeted therapy in renal cell carcinoma: Current status and future directions
Brian I. Rini
CLINICAL CANCER RESEARCH (2007)
Targeted therapy for metastatic renal cell carcinoma
Robert J. Motzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Immunotherapy for renal cell cancer
James C. Yang et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Pathway analysis of kidney cancer using proteomics and metabolic profiling
Bertrand Perroud et al.
MOLECULAR CANCER (2006)
Proteomic identification of a role for the von Hippel Lindau tumour suppressor in changes in the expression of mitochondrial proteins and septin 2 in renal cell carcinoma
Rachel A. Craven et al.
PROTEOMICS (2006)
Novel blood biomarkers of human urinary bladder cancer
I Osman et al.
CLINICAL CANCER RESEARCH (2006)
Classification of renal neoplasms based on molecular signatures
Ximing J. Yang et al.
JOURNAL OF UROLOGY (2006)
Identification of Dll1 (Delta1) target genes during mouse embryogenesis using differential expression profiling
C Machka et al.
GENE EXPRESSION PATTERNS (2005)
Renal cell carcinoma: Current status and future prospects
BJ Drucker
CANCER TREATMENT REVIEWS (2005)
Calcium signaling in cancer and vitamin D
IN Sergeev
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2005)
Prolonged low dose IL-2 and thalidomide in progressive metastatic renal cell carcinoma with concurrent radiotherapy to bone and/or soft tissue metastasis: a phase II study
JM Kerst et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Identification of fatty acid binding proteins as markers associated with the initiation and/or progression of renal cell carcinoma
B Seliger et al.
PROTEOMICS (2005)
Biological actions and mechanism of action of calbindin in the process of apoptosis
S Christakos et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2004)
Down-regulation of HLA class I antigen processing molecules:: An immune escape mechanism of renal cell carcinoma?
D Atkins et al.
JOURNAL OF UROLOGY (2004)
Gene expression profiling of renal cell carcinoma
MH Tan et al.
CLINICAL CANCER RESEARCH (2004)
Using protein expressions to predict survival in clear cell renal carcinoma
HL Kim et al.
CLINICAL CANCER RESEARCH (2004)
Expression of heat shock protein 27 in human renal cell carcinoma
C Sarto et al.
PROTEOMICS (2004)
Ontogeny and oncogenesis balance the transcriptional profile of renal cell cancer
E Wang et al.
CANCER RESEARCH (2004)
Expression of heart-type fatty acid-binding protein in human gastric carcinoma and its association with tumor aggressiveness, metastasis and poor prognosis
T Hashimoto et al.
PATHOBIOLOGY (2004)
Differential protein profiling in renal-cell carcinoma
T Shi et al.
MOLECULAR CARCINOGENESIS (2004)
Molecular subclassification of kidney tumors and the discovery of new diagnostic markers
M Takahashi et al.
ONCOGENE (2003)
Identification of markers for the selection of patients undergoing renal cell carcinoma-specific immunotherapy
B Seliger et al.
PROTEOMICS (2003)
Correlation of Ki-67 and gelsolin expression to clinical outcome in renal clear cell carcinoma
H Visapää et al.
UROLOGY (2003)
Use of a sensitive EnVision™+-based detection system for Western blotting:: avoidance of streptavidin binding to endogenous biotin and biotin-containing proteins in kidney and other tissues
RE Banks et al.
PROTEOMICS (2003)
Identification of metabolic enzymes in renal cell carcinoma utilizing PROTEOMEX analyses
R Lichtenfels et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2003)
Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray
JPT Higgins et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Overexpression of KIT in chromophobe renal cell carcinoma
K Yamazaki et al.
ONCOGENE (2003)
The changing natural history of renal cell carcinoma
AJ Pantuck et al.
JOURNAL OF UROLOGY (2001)
Parvalbumin is constantly expressed in chromophobe renal carcinoma
G Martignoni et al.
MODERN PATHOLOGY (2001)
Expression profiling of renal epithelial neoplasms - A method for tumor classification and discovery of diagnostic molecular markers
AN Young et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Proteomics: Current technologies and applications in neurological disorders and toxicology
M Fountoulakis
AMINO ACIDS (2001)
Calbindin-D28k is expressed in osteoblastic cells and suppresses their apoptosis by inhibiting caspase-3 activity
T Bellido et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
The fatty acid transport function of fatty acid-binding proteins
J Storch et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2000)
Share Paper
